Betahistine (16mg)+ Vitamin D3 (400IU)+ Ginkgo Biloba (60mg)+ Piracetam (400mg)+ Vinpocetine (5mg)
Otolanz PV Tablet can be taken with or without food. It should be used in the dose and duration as prescribed by your doctor. This medicine should not be consumed more than the recommended dose.Some common side effects include headache, nervousness, fatigue, and stomach upset. These are usually well tolerated but if these side effects persist for a long time, please consult your doctor. Contact your doctor immediately if you notice any symptoms of allergic reactions like swelling, itching, difficulty in breathing, hives, etc.Before taking this medicine, tell your doctor if you have any other health conditions. Inform your doctor if you are taking any other medicines or if you are pregnant or breastfeeding. It is advised not to consume alcohol after taking this medicine.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about themCommon side effects of Otolanz PV
10 tablets
Vasu Organics Pvt Ltd
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Otolanz PV Tablet may be taken with or without food, but it is better to take it at a fixed time.
Otolanz PV Tablet is a combination of five medicines: Betahistine, Vitamin D3, Ginkgo Biloba, Piracetam and Vinpocetine. Betahistine improves blood flow in the inner ear which reduces the pressure of excess fluid in the inner ear. Vitamin D3 is added as it's deficiency may be a cause of Miniere's disease. Ginkgo Biloba and Vinpocetine increase blood flow to the brain and protect it from damage by harmful chemical substances (free radicals). Piracetam works by further protecting the brain and nervous system against shortness of oxygen and also affects various channels on nerve cells.
Related Warnings
Caution is advised when consuming alcohol with Otolanz PV Tablet. Please consult your doctor.
Otolanz PV Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Otolanz PV Tablet during breastfeeding is not available. Please consult your doctor.
Otolanz PV Tablet may cause side effects which could affect your ability to drive.
Otolanz PV Tablet may cause drowsiness and shakiness. This may affect your driving ability.
Otolanz PV Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Otolanz PV Tablet may not be needed in these patients. Please consult your doctor.
Otolanz PV Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Otolanz PV Tablet may not be needed in these patients. Please consult your doctor.
Keep this medicine in the packet or the container it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children and other people.
Otolanz PV Tablet may cause indigestion. Take it with or after food to avoid Indigestion. Talk to your doctor if you are suffering from regular indigestion.
Visit the nearest emergency department if you accidentally take too much of this medicine. Symptoms of taking too much of Otolanz PV Tablet may include tiredness, pupil dilation, inability to urinate, dry mouth, flushing, fast heart rate, sweating, headache, dizziness, and shakiness.
You should not stop taking Otolanz PV Tablet until your doctor informs you to stop it. If you stop taking Otolanz PV Tablet earlier than advised, the symptoms of vertigo may reappear (dizziness and spinning).
